Back to search

Italy· 049685035

EVRENZO*12x1 cpr rivestite 70 mg dose unitaria

A roxadustat product containing roxadustat, registered in Italy by ASTELLAS PHARMA EUROPE B.V., on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC B03XA05

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedEVRENZO*12x1 cpr rivestite 70 mg dose…ATCB03XA05REGISTER NO.049685035PACKS LISTED1CHECKEDJune 4, 2026

Where it is registered

Roxadustat is registered in 13 of 19 countries.

Countries holding a registration under ATC B03XA05 (roxadustat), each read from that country’s own register.

  • This record: Italy
  • 8 of them publish a price we can compare per daily dose

Roxadustat · ATC B03XA05

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of roxadustat costs, country by country.

Normalised to the WHO defined daily dose (43 mg), the median price runs from $23.73 in Italy to $77.81 in France — a ×3.3 gap.

  • Italy: $23.73 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Roxadustat · price per daily dose (43 mg)

USD · FX 28 Sept 2026

  • FR France$77.81
  • IT Italy$23.73
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Active substance
Roxadustat
Manufacturer
ASTELLAS PHARMA EUROPE B.V.
Country
Italy (IT)
ATC code
B03XA05
ATC class
Roxadustat
Defined daily dose
43 mg, O
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    049685035
    EVRENZO*12x1 cpr rivestite 70 mg dose unitaria
    EUR 407.12

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Roxadustat in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All roxadustat products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Evrenzo
  • Liechtenstein · Evrenzo
  • Norway · Evrenzo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bf1bff7d-c26e-4f89-9d0a-8a281157c5ca
GET /v1/drugs/bf1bff7d-c26e-4f89-9d0a-8a281157c5ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 407.12,
  "source": "aifa",
  "currency": "EUR",
  "strength": "ROXADUSTAT 70MG 12 UNITA' USO ORALE",
  "substance": "Roxadustat",
  "equivalence_group": "MKW",
  "transparency_flag": null
}

See everything about roxadustat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.